Zero idea, why this has started this very welcomed run, as I don't have that disease but have people / a person take their blood almost every other hour ... so if there was an inhaler available .... This might revolutionize a very serious medical problem.
How come, "If further studies required, or 1 more specific study as per FDA, then what..."
Then MNKD would be asked to do this as a long tern study after approval. When Exubra was approved it was asked to conduct tests regarding effect on proper functioning of patients lungs.
Mnkd has been already asked to do likewise.
This does not stop the FDA from approving Afrezza.
This risk applies to all new drugs. Your inability to pay the current pps is no reason to wish that the price falls. You must be aq member of the me me me club.